Active Clinical Trials

red-content-divider.png

The Following are Clinical Trials Currently Under Study.

Please note: Not all "active trials" are currently recruiting patients. Active trials are currently underway and some may therefore no longer be recruiting patients. For trials that are currently recruiting patients, please check our current recruitment page here.

 


For patients who have been diagnosed with DIABETIC RETINOPATHY

1 | Regeneron
The primary objective of the study is to assess the efficacy of intravitreal (IVT) aflibercept compared to sham treatment in the improvement of moderately severe to severe nonproliferative diabetic retinopathy (NPDR).

 

For patients who have been diagnosed with Alzheimer'S Disease

1 | Merck
Phase 2/3 study to examine and test for retinal effects and visual changes while being administered disease specific study drug for dementia.

 

Genetic Studies

1 | GARM II
Study designed to observe and identify the risk factors that contribute to genetic Age Related Macular Degeneration.

2 | eyeGENE
Study designed to assist in Blood/DNA collection for the National Ophthalmic Disease Genotyping and Phenotyping Network.

 

 

Attention Patients and Doctors

If you are interested in obtaining more information or would like to enroll in one of these studies, please contact CFR’s Clinical Research Department at clinicalresearch@cfretina.com.